Diet and lifestyle modification remains the mainstay of treatment. For patients with NASH and advanced fibrosis, current liver-directed drugs with vitamin E and liver-specific drugs like pioglitazone offer some benefits, Newer medications like obeticholic acid appears promising and is currently being tested.
Comorbidities must be diagnosed and treated; cardiovascular disease remains a primary cause of death in these patients.